Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Swindell

Showing results (191-200 of 284) with videos related to

Pageof 29
Sort By:
British Journal of Cancer|May 1, 1987
DNA analysis by flow cytometry, response to endocrine treatment and prognosis in advanced carcinoma of the breastA D Baildam, J Zaloudik, A Howell, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1988
Comparative toxicity of cisplatin, carboplatin (CBDCA) and iproplatin (CHIP) in combination with cyclophosphamide in patients with advanced epithelial ovarian cancerH Anderson, J Wagstaff, D Crowther, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 2, 2010
Can synchronous chemotherapy be added to accelerated hypofractionated radiotherapy in patients with base of tongue cancer?A Jegannathen, R Swindell, B Yap, et al.
Clinical and Translational Medicine|April 18, 2015
Psoriasis drug development and GWAS interpretation through in silico analysis of transcription factor binding sitesWilliam R Swindell, Mrinal K Sarkar, Philip E Stuart, et al.
The Journal of Laryngology and Otology|February 13, 2013
Value of the Hospital Anxiety and Depression Scale in the follow up of head and neck cancer patientsL A Joseph, J A Routledge, M P Burns, et al.
Chemotherapy|May 3, 2013
Cisplatin plus capecitabine as first-line chemotherapy for recurrent or metastatic head and neck squamous cell cancer: experience outside of a trial settingA J McPartlin, K Mais, C Barker, et al.
British Journal of Cancer|February 9, 2005
Treatment of inoperable hepatocellular carcinoma with pegylated liposomal doxorubicin (PLD): results of a phase II studyJ W Valle, A Dangoor, J Beech, et al.
British Journal of Cancer|November 1, 1980
Serum glycoprotein hormone alpha subunit, hormone receptors and disease stage in patients with breast cancerI A MacFarlane, D Barnes, J M Howat, et al.
BMC Medical Genomics|June 3, 2014
Cellular dissection of psoriasis for transcriptome analyses and the post-GWAS eraWilliam R Swindell, Philip E Stuart, Mrinal K Sarkar, et al.
British Journal of Haematology|September 6, 2000
Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescueA M Wardley, G C Jayson, R Swindell, et al.
Pageof 29

Showing results (191-200 of 284) with videos related to

Sort By:
Pageof 29
British Journal of Cancer|May 1, 1987
DNA analysis by flow cytometry, response to endocrine treatment and prognosis in advanced carcinoma of the breastA D Baildam, J Zaloudik, A Howell, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1988
Comparative toxicity of cisplatin, carboplatin (CBDCA) and iproplatin (CHIP) in combination with cyclophosphamide in patients with advanced epithelial ovarian cancerH Anderson, J Wagstaff, D Crowther, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 2, 2010
Can synchronous chemotherapy be added to accelerated hypofractionated radiotherapy in patients with base of tongue cancer?A Jegannathen, R Swindell, B Yap, et al.
Clinical and Translational Medicine|April 18, 2015
Psoriasis drug development and GWAS interpretation through in silico analysis of transcription factor binding sitesWilliam R Swindell, Mrinal K Sarkar, Philip E Stuart, et al.
The Journal of Laryngology and Otology|February 13, 2013
Value of the Hospital Anxiety and Depression Scale in the follow up of head and neck cancer patientsL A Joseph, J A Routledge, M P Burns, et al.
Chemotherapy|May 3, 2013
Cisplatin plus capecitabine as first-line chemotherapy for recurrent or metastatic head and neck squamous cell cancer: experience outside of a trial settingA J McPartlin, K Mais, C Barker, et al.
British Journal of Cancer|February 9, 2005
Treatment of inoperable hepatocellular carcinoma with pegylated liposomal doxorubicin (PLD): results of a phase II studyJ W Valle, A Dangoor, J Beech, et al.
British Journal of Cancer|November 1, 1980
Serum glycoprotein hormone alpha subunit, hormone receptors and disease stage in patients with breast cancerI A MacFarlane, D Barnes, J M Howat, et al.
BMC Medical Genomics|June 3, 2014
Cellular dissection of psoriasis for transcriptome analyses and the post-GWAS eraWilliam R Swindell, Philip E Stuart, Mrinal K Sarkar, et al.
British Journal of Haematology|September 6, 2000
Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescueA M Wardley, G C Jayson, R Swindell, et al.
Pageof 29